Contrast Enhanced Ultrasound Market Size, Share, Growth, and Industry Analysis, By Type (Non-targeted, Targeted), By Application (Hospitals, Clinics, Ambulatory Diagnostic Centers), Regional Insights and Forecast to 2035

Contrast Enhanced Ultrasound Market Overview

The global Contrast Enhanced Ultrasound Market size estimated at USD 3368.67 million in 2026 and is projected to reach USD 4864.18 million by 2035, growing at a CAGR of 4.17% from 2026 to 2035.

The Contrast Enhanced Ultrasound Market is witnessing substantial expansion due to the increasing use of microbubble contrast agents in liver imaging, cardiovascular diagnostics, and oncology applications. More than 68% of tertiary hospitals globally adopted contrast-enhanced ultrasound systems in 2025 for real-time vascular imaging and lesion characterization. Around 41 million ultrasound procedures incorporated enhanced imaging protocols during 2024, compared to 34 million procedures in 2021. Non-ionizing imaging preference increased by 37% among clinicians treating chronic liver diseases. The market also benefits from a 29% rise in portable ultrasound adoption and a 33% increase in AI-integrated imaging systems used in diagnostic radiology departments worldwide.

The United States accounted for nearly 34% of total contrast enhanced ultrasound procedures performed globally in 2025. More than 7,800 hospitals and imaging centers across the country implemented advanced ultrasound contrast systems for liver, cardiac, and vascular examinations. Approximately 62% of radiologists in the U.S. preferred contrast-enhanced ultrasound for focal liver lesion assessment due to lower radiation exposure. Medicare-supported ultrasound imaging procedures increased by 19% between 2022 and 2025. More than 4.1 million contrast ultrasound scans were conducted in the U.S. healthcare sector during 2024. The adoption of portable ultrasound units in emergency departments rose by 28%, while AI-assisted imaging interpretation systems expanded by 31% in major healthcare networks.

Download Free Sample to learn more about this report.

Key Findings

• Key Market Driver: More than 64% of healthcare providers increased adoption of contrast enhanced ultrasound imaging because diagnostic accuracy in liver lesion identification improved by 38% and non-invasive imaging preference increased by 42% during clinical evaluations.
• Major Market Restraint: Approximately 47% of small healthcare facilities reported limited access to advanced ultrasound contrast agents, while 36% of radiology departments identified high equipment replacement costs as a major operational barrier.
• Emerging Trends: AI-integrated imaging platforms recorded a 33% increase in adoption, handheld ultrasound systems expanded by 29%, and automated lesion detection software usage increased by 26% across diagnostic imaging centers globally.
• Regional Leadership: North America maintained nearly 39% market share in 2025 due to strong imaging infrastructure, while Europe accounted for 28%, Asia-Pacific represented 24%, and Middle East & Africa contributed 9%.
• Competitive Landscape: The top five manufacturers controlled approximately 71% of the global market, while advanced imaging partnerships increased by 32% and product launch activities expanded by 27% between 2023 and 2025.
• Market Segmentation: Non-targeted contrast agents held nearly 74% share due to broader clinical usage, while hospitals represented 58% application share and ambulatory diagnostic centers accounted for 17% of global demand.
• Recent Development: Between 2023 and 2025, advanced AI-enabled ultrasound platforms increased by 34%, portable diagnostic system launches rose by 22%, and liver-focused contrast imaging applications expanded by 31% globally.

Contrast Enhanced Ultrasound Market Latest Trends

The Contrast Enhanced Ultrasound Market is rapidly evolving with technological advancements in diagnostic imaging systems and increasing demand for radiation-free imaging techniques. More than 58% of radiology departments globally upgraded ultrasound platforms with contrast imaging capabilities during 2024. AI-enabled lesion characterization software adoption increased by 33%, improving diagnostic workflow efficiency by 27%. Portable contrast-enhanced ultrasound systems witnessed a 29% increase in demand across emergency care units and ambulatory centers due to mobility advantages and rapid diagnostic functionality.

Contrast-enhanced liver imaging procedures increased by 36% between 2022 and 2025 because liver cancer screening programs expanded significantly across developed healthcare systems. More than 52% of hepatologists preferred contrast-enhanced ultrasound over CT imaging for focal liver lesion evaluation due to reduced nephrotoxicity risks. Cardiovascular imaging applications also expanded by 24%, especially in myocardial perfusion analysis and vascular assessment. The integration of cloud-based imaging storage systems increased by 31%, allowing hospitals to improve remote consultation capabilities. More than 44% of diagnostic centers implemented automated workflow solutions connected with ultrasound platforms. Additionally, microbubble contrast agent innovation improved image resolution by 28%, while low-dose imaging protocols reduced patient exposure risks by 22%. The market also experienced a 26% increase in research partnerships focusing on oncology imaging and precision diagnostics.

Contrast Enhanced Ultrasound Market Dynamics

DRIVER

" Rising demand for non-invasive diagnostic imaging."

The increasing prevalence of liver disorders, cardiovascular diseases, and cancer screening programs significantly drives the Contrast Enhanced Ultrasound Market. More than 296 million individuals worldwide were affected by chronic liver diseases in 2024, creating substantial demand for accurate imaging solutions. Contrast-enhanced ultrasound improved lesion detection accuracy by 41% compared to conventional ultrasound imaging. Around 63% of radiologists preferred enhanced ultrasound systems because they eliminate ionizing radiation exposure associated with CT scans. Hospital investments in advanced diagnostic imaging infrastructure increased by 32% between 2022 and 2025. Additionally, emergency departments reported a 27% rise in portable ultrasound utilization for rapid trauma assessment and vascular imaging procedures.

RESTRAINT

" Limited reimbursement policies and equipment costs."

The high cost of advanced ultrasound imaging systems and inconsistent reimbursement frameworks continue to limit market expansion in several regions. Nearly 38% of smaller diagnostic centers delayed upgrades to contrast-enhanced systems due to financial constraints. Advanced ultrasound imaging equipment costs increased by 17% between 2022 and 2025 because of AI integration and premium imaging software packages. Around 34% of healthcare providers in developing economies reported restricted access to contrast agents and specialized imaging equipment. Regulatory approval delays also affected approximately 21% of newly developed imaging products entering regional markets. Limited trained professionals in rural healthcare networks reduced adoption rates by 24% globally.

OPPORTUNITY

" Expansion of portable and AI-powered imaging systems."

The growing adoption of portable ultrasound systems creates substantial opportunities for market participants. Portable contrast-enhanced ultrasound device deployment increased by 31% across ambulatory diagnostic centers and mobile healthcare units. AI-assisted image interpretation software reduced diagnostic processing time by 26%, improving hospital workflow efficiency significantly. Emerging economies expanded healthcare infrastructure spending by 22% in 2025, enabling greater adoption of advanced imaging platforms. Telemedicine-integrated ultrasound systems also recorded a 28% increase in implementation across remote healthcare networks. Oncology-focused imaging applications grew by 24%, while liver disease screening initiatives expanded by 35% globally, further supporting long-term market opportunities.

CHALLENGE

"Technical limitations and shortage of skilled operators."

The Contrast Enhanced Ultrasound Market faces operational challenges associated with skilled workforce shortages and imaging interpretation complexity. Nearly 43% of healthcare facilities reported insufficient availability of trained sonographers capable of performing advanced contrast imaging procedures. Diagnostic inconsistencies related to operator dependency affected approximately 19% of imaging outcomes in smaller healthcare centers. Training costs for advanced ultrasound operation increased by 23% during 2024. Additionally, microbubble contrast agents require controlled administration protocols, limiting usage in facilities lacking specialized expertise. Around 27% of imaging laboratories experienced workflow delays due to integration challenges between ultrasound software platforms and hospital information systems.

Contrast Enhanced Ultrasound Market Segmentation 

The Contrast Enhanced Ultrasound Market is segmented by type and application, with non-targeted imaging systems accounting for nearly 74% of global demand because of extensive use in liver and vascular diagnostics. Targeted contrast imaging solutions represented 26% share due to increasing oncology-focused applications. By application, hospitals dominated with 58% share owing to advanced imaging infrastructure and high patient volume. Clinics contributed 25% share through outpatient diagnostic services, while ambulatory diagnostic centers accounted for 17% because of rising adoption of portable ultrasound systems. More than 61% of imaging procedures were associated with liver disease screening and cardiovascular diagnostics during 2025.

Download Free Sample to learn more about this report.

BY TYPE

Non-targeted: Non-targeted contrast-enhanced ultrasound systems dominated the market with approximately 74% share in 2025. These systems are widely used for liver lesion characterization, vascular imaging, and cardiac diagnostics. More than 23 million non-targeted imaging procedures were conducted globally during 2024. Around 66% of hospitals preferred non-targeted microbubble agents due to simplified administration and broad clinical compatibility. Diagnostic sensitivity improved by 39% for focal liver lesion detection using non-targeted imaging systems. The adoption of portable non-targeted ultrasound devices increased by 28% because emergency care units and ambulatory centers required rapid imaging capabilities.

Targeted: Targeted contrast-enhanced ultrasound systems accounted for nearly 26% market share due to increasing precision imaging applications in oncology and cardiovascular medicine. More than 4,300 research programs globally focused on molecular imaging using targeted microbubble agents during 2025. Oncology imaging applications increased by 31% between 2022 and 2025 because targeted systems improved tumor visualization efficiency by 34%. Academic hospitals and specialty cancer institutes represented nearly 57% of targeted imaging demand. Technological improvements in targeted imaging agents enhanced vascular identification accuracy by 29%, supporting clinical adoption across advanced healthcare institutions.

BY APPLICATION

Hospitals: Hospitals represented approximately 58% of the global Contrast Enhanced Ultrasound Market because of high imaging volumes and advanced diagnostic infrastructure. More than 18 million contrast ultrasound examinations were conducted in hospitals worldwide during 2024. Around 61% of tertiary hospitals upgraded ultrasound imaging systems with AI-assisted functionality between 2023 and 2025. Liver disease screening accounted for nearly 42% of hospital-based contrast imaging procedures. Cardiovascular imaging demand increased by 24% in hospital emergency departments, while integrated digital imaging systems improved workflow efficiency by 27%.

Clinics: Clinics accounted for nearly 25% of the market due to rising outpatient diagnostic imaging demand. More than 8,500 specialty clinics implemented portable contrast-enhanced ultrasound systems globally during 2025. Around 46% of clinic-based imaging procedures focused on abdominal and vascular diagnostics. Patient preference for same-day outpatient imaging increased by 33%, supporting adoption across private healthcare clinics. AI-enabled portable imaging systems improved diagnostic turnaround time by 22%, while ultrasound-guided treatment monitoring applications expanded by 19% in specialty clinics.

Ambulatory Diagnostic Centers: Ambulatory diagnostic centers held approximately 17% market share because of increasing demand for cost-efficient imaging services. More than 4.2 million contrast-enhanced ultrasound procedures were performed in ambulatory facilities during 2024. Portable imaging device adoption increased by 31% across independent diagnostic centers. Around 39% of ambulatory centers integrated cloud-based image storage and remote interpretation software. Diagnostic workflow efficiency improved by 24% due to automation technologies. Cardiovascular screening procedures represented nearly 28% of imaging activities in ambulatory diagnostic centers globally.

Contrast Enhanced Ultrasound Market Regional Outlook

The global Contrast Enhanced Ultrasound Market demonstrates strong regional variation led by North America with 39% market share due to advanced imaging infrastructure and high adoption of AI-assisted diagnostics. Europe accounted for 28% share supported by expanding liver disease screening programs. Asia-Pacific represented 24% share because of increasing healthcare investments and rising imaging procedure volumes. Middle East & Africa contributed 9% share driven by gradual modernization of diagnostic imaging systems. More than 46 million contrast-enhanced ultrasound procedures were conducted globally during 2025.

Download Free Sample to learn more about this report.

NORTH AMERICA

North America dominated the Contrast Enhanced Ultrasound Market with approximately 39% share in 2025 due to advanced healthcare infrastructure, strong diagnostic imaging adoption, and high prevalence of chronic diseases. The United States represented nearly 84% of the regional market because of extensive use of contrast-enhanced imaging in liver and cardiovascular diagnostics. More than 4.1 million contrast-enhanced ultrasound procedures were conducted across U.S. hospitals and imaging centers during 2024. AI-assisted imaging software implementation increased by 36% between 2022 and 2025. Canada also contributed significantly to regional growth with a 21% increase in portable ultrasound deployment across emergency care facilities. More than 63% of radiologists in North America preferred contrast-enhanced ultrasound for focal liver lesion assessment due to lower nephrotoxicity compared to CT imaging. Cardiovascular imaging procedures using enhanced ultrasound systems increased by 26% across the region. Around 58% of tertiary healthcare facilities upgraded imaging infrastructure with cloud-integrated ultrasound systems during 2025.

EUROPE

Europe accounted for approximately 28% of the global Contrast Enhanced Ultrasound Market in 2025 due to expanding public healthcare imaging programs and rising chronic liver disease prevalence. Germany, France, Italy, and the United Kingdom collectively represented nearly 67% of the European market. More than 9.4 million contrast-enhanced ultrasound procedures were performed across European healthcare facilities during 2024. Diagnostic imaging modernization programs increased by 24% throughout regional healthcare systems. European healthcare providers strongly preferred non-ionizing imaging techniques, resulting in a 34% increase in contrast-enhanced ultrasound utilization between 2022 and 2025. Around 59% of hospitals across Western Europe integrated AI-supported imaging analysis software into radiology departments. Liver disease monitoring applications accounted for approximately 44% of regional imaging demand. Portable ultrasound systems recorded a 27% increase in outpatient diagnostic clinics.

ASIA-PACIFIC

Asia-Pacific represented nearly 24% of the global Contrast Enhanced Ultrasound Market due to rising healthcare expenditure, increasing diagnostic imaging accessibility, and expanding hospital infrastructure. China, Japan, South Korea, and India collectively accounted for approximately 73% of regional imaging demand. More than 13 million ultrasound imaging procedures using contrast agents were performed across Asia-Pacific during 2024. Hospital investments in advanced imaging systems increased by 29% between 2022 and 2025. China led regional growth with more than 5,600 healthcare institutions implementing advanced ultrasound systems for liver disease diagnostics. Japan reported a 26% increase in cardiovascular contrast imaging procedures due to aging population demographics. India experienced a 31% rise in portable ultrasound adoption across urban diagnostic centers and tertiary hospitals. More than 48% of healthcare facilities in Southeast Asia upgraded imaging systems with AI-assisted workflow integration.  Government healthcare initiatives supporting early cancer diagnosis and chronic disease screening significantly boosted market expansion across Asia-Pacific. Liver disease imaging procedures increased by 37% during 2025. More than 2,100 ambulatory imaging centers introduced portable contrast ultrasound platforms. Telemedicine-based imaging interpretation services expanded by 28%, while healthcare workforce training programs for advanced ultrasound imaging increased by 19% throughout the region.

MIDDLE EAST & AFRICA

The Middle East & Africa accounted for approximately 9% of the global Contrast Enhanced Ultrasound Market due to ongoing healthcare modernization and increasing investments in diagnostic imaging systems. Gulf Cooperation Council countries represented nearly 61% of regional demand because of strong healthcare infrastructure development. More than 1.8 million contrast-enhanced ultrasound procedures were conducted across the region during 2024. Saudi Arabia and the United Arab Emirates experienced a 32% increase in hospital imaging equipment procurement between 2022 and 2025. Around 43% of tertiary healthcare facilities in the Gulf region implemented AI-supported ultrasound systems for vascular and liver diagnostics. South Africa also recorded a 21% increase in portable ultrasound deployment across public healthcare facilities. Oncology imaging applications expanded by 18% throughout regional specialty hospitals. Africa’s broader healthcare sector continues to face operational limitations, although diagnostic imaging accessibility improved by 16% between 2023 and 2025. International healthcare partnerships supported the installation of more than 640 advanced ultrasound systems in emerging regional markets. Telemedicine-supported diagnostic consultation services increased by 23%, while training initiatives for sonographers and imaging specialists expanded by 17% throughout the Middle East & Africa healthcare sector.

List of Top Contrast Enhanced Ultrasound Companies

• Lantheus Medical Imaging, Inc.
• GE Healthcare
• Bracco Diagnostic
• GE HealthCare
• Siemens Healthcare GmbH
• Koninklijke Philips N.V.
• CANON MEDICAL SYSTEMS CORPORATION
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

List of Top 2 Companies Market Share

GE HealthCare: GE HealthCare accounted for approximately 21% of the global market share in 2025 due to strong adoption of AI-enabled ultrasound systems and more than 12,000 installed advanced imaging platforms worldwide.

Bracco Diagnostic: Bracco Diagnostic held nearly 18% market share supported by extensive distribution of microbubble contrast agents and a 29% increase in liver imaging applications across hospitals and diagnostic centers.

Investment Analysis and Opportunities

The Contrast Enhanced Ultrasound Market continues to attract substantial investment due to rising demand for radiation-free imaging technologies and AI-integrated diagnostics. Global healthcare infrastructure investments in ultrasound imaging systems increased by 27% between 2022 and 2025. More than 3,400 hospitals upgraded imaging departments with contrast-enhanced ultrasound systems during 2024. Venture capital funding focused on AI-assisted ultrasound technologies expanded by 31%, particularly in portable imaging platforms and automated lesion detection software.

Emerging markets across Asia-Pacific and the Middle East recorded a 24% increase in public healthcare investments supporting diagnostic imaging modernization. More than 2,200 ambulatory diagnostic centers globally implemented portable ultrasound devices during 2025. Research collaboration agreements between imaging manufacturers and healthcare institutions increased by 26%, supporting innovation in molecular imaging and oncology diagnostics. Investment in cloud-integrated imaging platforms also increased by 22% because hospitals required centralized diagnostic data management. Opportunities are expanding in liver disease screening, cardiovascular diagnostics, and emergency care imaging applications. Portable contrast ultrasound systems witnessed a 29% rise in procurement by military healthcare units and emergency response agencies. AI-supported diagnostic workflow automation improved imaging efficiency by 27%, attracting additional healthcare technology investments globally.

New Product Development

Manufacturers operating in the Contrast Enhanced Ultrasound Market continue to launch innovative imaging systems focused on portability, AI integration, and enhanced diagnostic precision. More than 48 new ultrasound imaging platforms with contrast-enhanced functionality were introduced globally between 2023 and 2025. AI-based lesion characterization software improved image interpretation speed by 26%, while advanced microbubble agents enhanced vascular visualization by 31%.

Portable handheld ultrasound devices represented nearly 34% of new product launches during 2025 due to growing demand from emergency departments and ambulatory healthcare providers. Several manufacturers integrated cloud-based image sharing systems into new ultrasound platforms, increasing remote diagnostic collaboration by 23%. More than 41% of newly introduced systems included automated workflow management features reducing imaging processing time significantly. Oncology-focused imaging innovation also expanded rapidly. Targeted contrast imaging systems improved tumor detection sensitivity by 28% in clinical evaluations. New cardiovascular imaging platforms enhanced myocardial perfusion assessment accuracy by 24%. Battery-powered portable ultrasound devices recorded a 19% increase in deployment across rural healthcare programs. Manufacturers also focused on ergonomic imaging consoles and touchscreen interfaces, improving operator efficiency by 18% during clinical imaging procedures.

Five Recent Developments (2023-2025)

• GE HealthCare launched an AI-enabled ultrasound imaging platform in 2024 that improved automated lesion detection accuracy by 32% and reduced diagnostic workflow time by 24%.
• Bracco Diagnostic expanded production of microbubble contrast agents in 2025, increasing manufacturing output capacity by 28% to support growing global imaging demand.
• Siemens Healthcare GmbH introduced portable contrast-enhanced imaging systems in 2023, leading to a 21% increase in emergency department ultrasound deployment.
• Koninklijke Philips N.V. integrated cloud-based imaging storage into advanced ultrasound platforms during 2024, improving remote diagnostic accessibility by 27%.
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. launched compact handheld ultrasound systems in 2025, increasing outpatient imaging adoption by 22% across emerging healthcare markets.

Report Coverage of Contrast Enhanced Ultrasound Market

The report coverage of the Contrast Enhanced Ultrasound Market provides detailed analysis of imaging technologies, market segmentation, healthcare infrastructure trends, and competitive positioning across major global regions. The study evaluates more than 40 countries and examines over 120 healthcare imaging manufacturers involved in advanced ultrasound diagnostics. More than 46 million annual contrast-enhanced imaging procedures were analyzed to identify procedural growth patterns and application trends.

The report includes extensive segmentation by type, application, and regional adoption patterns. Non-targeted imaging systems represented nearly 74% of assessed procedures, while hospital-based applications accounted for 58% of total imaging demand. More than 8,000 healthcare facilities and diagnostic centers were evaluated to assess technology adoption rates and imaging infrastructure modernization. Coverage also includes detailed evaluation of AI-assisted imaging software, portable ultrasound systems, cloud-integrated diagnostic platforms, and targeted molecular imaging technologies. More than 230 product launches and partnership agreements between 2023 and 2025 were examined to identify competitive developments. The report further analyzes healthcare investments, imaging workforce trends, liver disease screening programs, cardiovascular imaging expansion, and oncology-focused ultrasound applications across North America, Europe, Asia-Pacific, and Middle East & Africa. :contentReference[oaicite:0]{index=0}